Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.54 |
| ▸ | S100A4 | P26447 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 3/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | USP8 | P40818 | 1/20 | 0.42 |
| ▸ | USP7 | Q93009 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31195807 | 1.00 | DNMT1 (0.54) | DNMT1S100A4MEN1ALDH1A1MAPT | |
| SCHEMBL19152440 | 0.93 | S100A4 (0.53) | DNMT1S100A4MEN1ALDH1A1MAPT | |
| SCHEMBL31106330 | 0.93 | S100A4 (0.53) | DNMT1S100A4MEN1ALDH1A1MAPT | |
| SCHEMBL14670621 | 0.83 | DNMT1 (0.64) | DNMT1S100A4MEN1ALDH1A1MAPT | |
| SCHEMBL3922177 | 0.82 | DNMT1 (0.71) | DNMT1MEN1ALDH1A1MAPTRAB9A | |
| SCHEMBL29466071 | 0.82 | DNMT1 (0.71) | DNMT1MEN1ALDH1A1MAPTRAB9A | |
| SCHEMBL4024897 | 0.81 | S100A4 (0.55) | DNMT1S100A4MEN1ALDH1A1MAPT | |
| SCHEMBL11657376 | 0.80 | S100A4 (0.53) | DNMT1S100A4MEN1ALDH1A1MAPT | |
| SCHEMBL27437092 | 0.80 | DNMT1 (0.54) | DNMT1S100A4MEN1ALDH1A1MAPT | |
| SCHEMBL12236188 | 0.80 | DNMT1 (0.67) | DNMT1MEN1ALDH1A1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-20220115596-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2022-04-14 | — | — | US | disclosed |
| EP-3919482-A1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | Solus Advanced Materials Co., Ltd. (KR) | 2021-12-08 | — | — | EP | disclosed |
| CN-112437770-A | Organic light-emitting compound and organic electroluminescent element using same | 索路思高新材料有限公司 | 2021-03-02 | — | — | CN | disclosed |
| WO-2020159019-A1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 두산솔루스 주식회사 | 2020-08-06 | — | — | WO | disclosed |
| WO-2020159019-A1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 두산솔루스 주식회사 | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220115596-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLC25A21, PIEZO1, SLCO4C1 | DNMT1 925/4885S100A4 2377/4885MEN1 2459/4885 |
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SLC25A21, PIEZO1, SLCO4C1 | DNMT1 925/4885S100A4 2377/4885MEN1 2459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.